1.A new cyclic diarylheptanoid from the bark of Myrica rubra.
Sheng-nan SHEN ; Fang-bo XIA ; He LI ; Ya-min LIU ; Rui-le PAN
Acta Pharmaceutica Sinica 2015;50(6):746-748
To study the chemical constituents from the bark of Myrica rubra, fourteen compounds were isolated from the methanolic extract using various chromatographic techniques, including silica gel, Sephadex LH-20 and preparative HPLC. Their structures were identified on the basis of chemical properties and spectroscopic data, as 3, 5-dimethoxy-4-hydroxymyricanol (1), myricanol (2), myricanone (3), myricanol 11-sulfate (4), myricitrin (5), quercetin (6), quercetin-3-rhamnoside (7), tamarixol (8), uvaol (9), ursolic acid (10), taraxerol (11), myricadiol (12), β-sitosterol (13) and β-daucosterol (14). Among them, compound 1 is a new compound, named as 3, 5-dimethoxy-4-hydroxymyricanol, compounds 8, 9 were isolated from the genus Myrica for the first time.
Diarylheptanoids
;
chemistry
;
isolation & purification
;
Myrica
;
chemistry
;
Phytochemicals
;
chemistry
;
isolation & purification
;
Plant Bark
;
chemistry
2.Application of gyrA and pare gene detection in genotyping of Ureaplasma spp.
Zhen ZHAO ; Ya HUANG ; Huifen PAN ; Min ZHOU ; Yuxing NI ; Qishi FAN
Chinese Journal of Microbiology and Immunology 2009;29(1):84-87
Objective To evaluate the contribution of gyrA and parE detection in Ureaplasma genotyping.Methods Sixty Ureaplasma isolates were selected with the Mycoplasma IST kit.The gyrA and parE were amplified by PCR.The DNA was sequenced and compared with the corresponding sequences in GenBank.Results The nucleotide sequence of gyrA had 100% identity in serovar 1,3,6,14 and 100%identity in serovar 2,4,5,7~13,too.But the sequence had 91%identity between the two groups.The nucleotide sequence of parE had 98%~99% identity in serovar 1,3,6,14.And it had 100% identity in erovar 2,5,7,8,11 and 100% identity in serovar4,12,13.But it had only 90% identity between the two groups.Ureaplasma parvum(Up),Ureaplasma urealyticum(Uu)and Up+Uu infection were found 68.3%(41/60),21.7%(13/60)and 10%(6/60) of clinical specimens,respectively.In Up isolates,serovar 3 was 48.8%(20/41).Conclusion Ureaplasma can be divided into two genotypes(Up and Uu)by gyrA analysis.And Up can be divided into four subtypes which correspond to serovar 1,3,6,14,respectively.Serovar 3 is the main isolate in our research.
3.Effects of catgut implantation at acupoint on learning and memory and LTP of the vascular dementia model rats
Can CHEN ; Qiong YANG ; Taoli DAI ; Ya PAN ; Xudong WANG ; Min ZHANG
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(03):-
Objective: To investigate the effects of point thread embedding on the learning and memory of the vascular dementia(VD) model rats and the possible mechanisms. Methods: VD rat models were established by employing improved method of Pulsinelli's four-vessel occlusion,then the model rats were treated with point thread embedding.Morris maze test was used to evaluate the learning and memory of the rats.In vivo recording of long term potentiation(LTP) was performed in the dentate gyrus of hippocampus and changes in each experimental group were observed and compared after high-frequency stimulation(HFS).Results: Compared with models group,the results from the Morris tests in treated group(thread embedding group)enhanced significantly(P
4.Protective effects of edaravone on diffuse brain injury in rats
Jian-Min LI ; Pan ZHANG ; Ya-Ning ZHAO ; Chang-Xiang CHEN ; Shu-Xing LI
World Journal of Emergency Medicine 2011;2(3):222-227
BACKGROUND: Edaravone can alleviate brain injury and improve neurological functions and symptoms. This study aimed to investigate the effect of edaravone on the p38Mitogen-activated protein kinases/Caspase-3 (p38MAPK /Caspase-3) pathway after diffuse brain injury (DBI) in rats. METHODS: DBI models were established according to the description of Marmarou's method. A total of 250 rats were divided (random number) into four groups: control group (CG, n=45), model group (MG, n=77), low-dose edaravone group (n=67, dosage 5 mg/kg) and high-dose edaravone group (n=61, dosage 10 mg/kg). After 1, 6, 24, 48, and 72 hours after injury, brain tissues were collected. The changes of neuron morphous in the hippocampal region were observed through Nissl staining. The expression levels of phosphorylated p38MAPK and caspase-3 were detected by immunohistochemistry and Western blotting respectively. Learning and memory function were tested with Morris water maze from the 3rd to 7th day after injury. RESULTS: Some neurons had histopathologic changes of necrosis and apoptosis in the model group compared with the control group. The phosphorylated p38MAPK expressions increased at 1, 6, 4, and 48 hours (P<0.05), but no significant difference was observed at 72 hours (0.54±0.19 vs. 0.40±0.14, P>0.05). Caspase-3 expressions increased at 6, 24, 48, and 72 hours respectively (P<0.05), but there was no significant difference at 1 hour (0.59±0.29 vs. 0.40±0.17, P>0.05). From the 3rd to 6th day during the Morris water maze test, the latency to find the platform was significantly prolonged (P<0.05) and times of rats crossing the platform was decreased on the 7th day (2.28±1.18 vs. 8.20±1.52, P<0.05). The phosphorylated p38MAPK expressions decreased at 6, 24 and 48 hours respectively in the low dose edaravone group compared with the model group (P<0.05), whereas no significant difference was seen at 1 hour (1.66±0.80 vs. 1.85±0.86, P>0.05). Caspase-3 expression decreased at 6, 24, 48, and 72 hours (P<0.05). The latency to find the platform was significantly shortened (P<0.05), and times of rats crossing the platform increased (4.17±1.15 vs. 2.28±1.18, P<0.05). The above mentioned parameters changed more significantly in the high-dose edaravone group than in the low-dose edaravone group. CONCLUSION: Edaravone can alleviate brain tissue damage after DBI, inhibit p38MAP signal activation after early injury, reduce the expression of caspase-3, and promote the recovery of neurological function in the late period.
5.Retrospective study on preventive usage of metal clip after EST
Biao GONG ; Shi WANG ; Li-Ke BIE ; Ya-Min PAN ; Xing-Ping LI ; Rui LU
Chinese Journal of Digestive Endoscopy 2001;0(03):-
Objective To study on the metal clip installation to avoid post-operative bleeding in pa- tients accepted papilla sphinctecotomy.Methods One hundred and eighty five patients who accepted ERCP +EST were divided into two groups:Group 1 was given routine regimen alone(N=95),group 2,given routine regimen and metal clip to prevent post-operative bleeding.Results The postoperative bleeding hap- pened in 3(3.2%)cases of Group 1 and none in Group 2,there is significant difference between these two groups(P<0.05).The breeding cases in group 1 were controlled by metal clip under endoscopy successful- ly.Conclusion Preventive usage of metal clip was significantly decreased the incidence of post-operative bleeding in EST patients.
6. Endoscopic management of biliary complications following liver transplantation: Strategies and skills
Academic Journal of Second Military Medical University 2013;34(3):235-239
Liver transplantation (LT) has become an important treatment for end stage hepatobiliary disorders. However, biliary complications following LT are common and greatly hamper the clinical efficacy. Endoscopic therapy has been the first-line modality for these biliary problems, though technically difficult and complex. We have managed more than 1 000 cases of complications following LT via endoscopic approach. Here we summarized the therapeutic methods and strategies of our center, hoping to provide evidence for better clinical practice.
7. Application of fully-covered self-expandable metallic stent for treatment of pancreatic-biliary diseases
Academic Journal of Second Military Medical University 2013;34(3):240-246
Objective To investigate the value, safety and efficacy of fully-covered self-expandable metallic stent (FCSEMS) in endoscopic retrograde cholangiopancreatography (ERCP) procedures for pancreatic-biliary diseases. Methods The clinical data of 56 patients with pancreatic-biliary diseases, who underwent FCSEMS treatment via ERCP from January 2008 to June 2012, were retrospectively analyzed. The stents of different lengths and types were chosen according to the condition of patients. The stentswere removed under endoscope. The therapeutic effects at end point, stent removing rate and associated complicationswere observed. Results FCSEMS was placed in 49 patients with benign stricture, including pos-- liver transplant stricture (32), iatrogenic biliary stricture (12) and chronic pancreatitis-associated stricture (5). The mean follow time was (15±8. 6) months (range 5-38 months), -the mean stent duration was (8.4±5. 3) months (1-15 months), and the effective rate was 89.8% (44/49). FCSEMS was placed in 7 patients with biliary complications, including bleeding after endoscopic sphincterotomy (EST) (4), perforation after EST (1), and bile leakage following liver transplantation (2). The mean follow time was (5±3. 7) months (range 1-12 months), themean stent duration was (1. 8±0. 5) months (1-8 months), and the effective rate was 100%. All FCSEMS were successfully retrieved. The short-term complication rate associated with stentwas 8.9% (5/56), including post-ERCP pancreatitis (2), early cholangitis (2) and cholecystitis (1). The long-term complication ratewas 12. 5% (7/56), including stent slip (2), stent translocation (3) and stent-associated cholangitis (2). Conclusion FCSEMS can not only be used to treat traditional benign pancreatic-biliary strictures, but alto serve as a potential substitute for safe and effective treatment of serious biliary complications.
8. Simultaneous stenting in bile duct and duodenum under endoscope for treatment of malignant biliary and duodenal obstruction
Academic Journal of Second Military Medical University 2013;34(3):261-265
Objective To investigate the therapeutic strategies, methods, safety and efficacy of simultaneous placement of sel--expanding metallic stent (SEMS) in the bile duct and duodenum under endoscope for treatment ofmalignant biliary and duodenal obstruction. Methods The clinical data of patients with obstructive jaundice combined with severe duodenal stricture, who were treated with simultaneous placement of biliary SEMS and duodental SEMS under endoscope during January 2009 to June 2012, were retrospectively analyzed. The success rate of endoscopic management, complications, relief of jaundice and results of gastric outlet obstruction scoring system (GOOSS) were analyzed. Results Totally ten patients meeting the criteria were analyzed in this study. The patients included 5 cases with pancreatic cancer, 2 with gallbladder cancer, 2 with cancer of bile duct and one with duodenal papilla caner. Five patients with type I duodenal stricture (without invading duodenal papilla) successfully received biliary stents through endoscopic retrograde cholangiopancreatography (ERCP) after placement of duodenal stents. One patient with type I duodenal stricture was implanted with a 9 cm duodenal stent before endoscopic anterograde cholangiopancreatography (EACP), then a SEMS was implanted in the bile duct through endoscopic ultrasonography-guided biliary drainage (EUS-BD). Three patientswith type H duodenal stricture (with invading duodenal papilla) underwent EACP and biliary stent placement through EUS-BD, and then the duodenal stent was deployed in duodenum after EACP. The patient with type m (away from the duodenal papilla) was implanted with biliary and duodenal stents. The success rate of endoscopic management was 100%. Two patients had self-controlled bleeding of intestinal mucosa, which was caused by endoscope friction when passing through the duodenal stricture, but without any continuous bleeding or perforation. Symptoms of jaundice and gastric outlet obstruction were greatly relieved after treatment. Conclusion For patients with unresectable malignant biliary obstruction combined with duodenal stricture, endoscopic placement of SEMS in the bile duct and duodenum simultaneously is a safe and effective method to palliate dual malignant obstruction via different endoscopic managements.
9.Neuroprotective effect of longistyline A against corticosterone-induced neurotoxicity in PC12 cells.
Bao-Ping JIANG ; Rui-Wu YANG ; Xin-Min LIU ; Ya-Min LIU ; Qi CHANG ; Jian-Yong SI ; Rui-Le PAN
Acta Pharmaceutica Sinica 2012;47(5):600-603
This study is to investigate the protective effect of longistyline A against corticosterone-induced neurotoxicity in PC12 cells. While PC12 cells were exposed to 100 micromol x L(-1) corticosterone for 48 h, cell survival rate was reduced and lactate dehydrogenase (LDH) release increased. In parallel, corticosterone caused significant elevations of DNA fragmentation, [Ca2+]i and caspase-3 activity. However, when the PC12 cells were incubated with longistyline A (4.0, 8.0 and 16.0 micromol x L(-1)) in the presence of 100 micromol x L(-1) corticosterone for 48 h, the effects were evidently alleviated, but dose-dependent manner was not obvious. In summary, longistyline A could generate a neuroprotective effect against corticosterone-induced neurotoxicity in PC12 cells possibly by decreasing [Ca2+]i and caspase-3 activity.
Animals
;
Cajanus
;
chemistry
;
Calcium
;
metabolism
;
Caspase 3
;
metabolism
;
Cell Survival
;
drug effects
;
Corticosterone
;
toxicity
;
DNA Fragmentation
;
drug effects
;
L-Lactate Dehydrogenase
;
metabolism
;
Molecular Structure
;
Neuroprotective Agents
;
isolation & purification
;
pharmacology
;
PC12 Cells
;
Phenols
;
isolation & purification
;
pharmacology
;
Plant Leaves
;
chemistry
;
Plants, Medicinal
;
chemistry
;
Rats
10.Study on pharmacological ingredients of wuzhuyu tang treating migraine by correlating absorption ingredients in everted intestinal sac and pharmacodynamics.
Xue-Qiang PAN ; Yan-Chuan WU ; Mu-Xin GONG ; Yong-Song XU ; Zhi-Min WANG ; Qi-Wei ZHANG ; Ya-Wen SHANG ; Xu-Ran LU ; Ya-Fang SONG
China Journal of Chinese Materia Medica 2014;39(1):126-133
Wuzhuyu Tang is a classical formula for treating migraine, but its' pharmacological ingredients is unclear yet. Present study employed the everted intestinal sac model to collect the absorption samples of 10 kinds of Wuzhuyu decoction, and then analyzed the contents of 9 ingredients in Wuzhuyu Tang and absorption samples quantitatively or semi-quantitatively by HPLC-DAD method. Reserpine was used to establish the mice model of migraine, and then the contents and activities of 5-hydroxytryptamine, noradrenaline, dopamine, nitric oxide and nitricoxide synthase in brain tissues and serums were determined respectively after oral administration of Wuzhuyu Tang. Using the partial least squares regression method to correlate the total absorption quantity of 9 ingredients and pharmacodynamics. The result shows that limocitrin-3-O-beta-D-glucoside, ginsenoside Rg1 and Rb1, rutaevine, limonin, evodiamine and rutaecarpine are the main ingredients influenced the effects in absorption samples in everted intestinal sacs, especially ginsenoside Rg1, rutaevine, evodiamine and rutaecarpine among them have obvious improving effects to most pharmacodynamics index, might be the pharmacological ingredients influenced the therapeutical effects of Wuzhuyu Tang treating migraine.
Animals
;
Drugs, Chinese Herbal
;
pharmacology
;
Female
;
Intestinal Absorption
;
drug effects
;
Intestines
;
drug effects
;
Male
;
Mice
;
Mice, Inbred ICR
;
Migraine Disorders
;
drug therapy
;
Rats
;
Rats, Wistar